Clinical Trial Update: Trial of Two Strains of BCG [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing two strains of BCG for morbidity outcomes; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacille Calmette-guérin
• Morbidity

Drugs mentioned

• BCG (Bacillus Calmette-Guérin)

Snippet

Sponsor: Bandim Health Project | Conditions: Morbidity, Bacille Calmette-Guérin | Phase 4 | Status: COMPLETED